SCHEMBL364008

SCHEMBL364008

OCc1ccc2c3c(ccc2c1)OC(c1ccccc1)(c1ccccc1)C=C3

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
NPC1 O15118 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
GLA P06280 1/20 0.34
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
KMT2A Q03164 1/20 0.34
HTT P42858 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HIF1A Q16665 1/20 0.32
AKR1B1 P15121 1/20 0.32
CA12 O43570 1/20 0.31
CA2 P00918 1/20 0.31
CA3 P07451 1/20 0.31
CA4 P22748 1/20 0.31
CA6 P23280 1/20 0.31
CA5A P35218 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4253743 0.83 APP (0.37) KDM4EMEN1NPC1ALDH1A1LMNA
SCHEMBL10026216 0.81 KDM4E (0.32) KDM4EMEN1NPC1ALDH1A1LMNA
SCHEMBL7263829 0.81 SIRT2 (0.38) KDM4EMEN1NPC1ALDH1A1LMNA
SCHEMBL30284250 0.81 SIRT2 (0.38) KDM4EMEN1NPC1ALDH1A1LMNA
SCHEMBL30284405 0.80 KDM4E (0.50) KDM4EMEN1NPC1ALDH1A1LMNA
SCHEMBL361847 0.80 KDM4E (0.50) KDM4EMEN1NPC1ALDH1A1LMNA
SCHEMBL361958 0.79 ALDH1A1 (0.32) KDM4EMEN1NPC1ALDH1A1LMNA
SCHEMBL7971753 0.78 HTT (0.36) KDM4EMEN1NPC1ALDH1A1LMNA
SCHEMBL5264237 0.78 CYP1A2 (0.41) KDM4EMEN1NPC1ALDH1A1LMNA
SCHEMBL20848052 0.77 KDM4E (0.39) KDM4EMEN1NPC1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8500807-B2 Photochromic intraocular lens CARL ZEISS MEDITEC SAS (FR) 2013-08-06 US disclosed
US-8500807-B2 Photochromic intraocular lens CARL ZEISS MEDITEC SAS (FR) 2013-08-06 US disclosed
EP-1753838-B1 POLYMERISABLE NAPHTHOPYRAN DERIVATIVES AND POLYMER MATERIALS OBTAINED FROM SAID DERIVATIVES POLYMEREXPERT S A (FR) 2012-03-14 EP disclosed
US-20100317805-A1 POLYMERISABLE NAPHTHOPYRANE DERIVATIVES AND POLYMER MATERIALS OBTAINED FROM THESE DERIVATIVES POLYMEREXPERT (FR) 2010-12-16 US disclosed
US-20100317805-A1 POLYMERISABLE NAPHTHOPYRANE DERIVATIVES AND POLYMER MATERIALS OBTAINED FROM THESE DERIVATIVES POLYMEREXPERT (FR) 2010-12-16 US disclosed
EP-1834195-B9 PHOTOCHROMIC INTRAOCULAR LENS IOLTECHNOLOGIE PRODUCTION (FR) 2010-07-21 EP disclosed
EP-1834195-B1 PHOTOCHROMIC INTRAOCULAR LENS IOLTECHNOLOGIE PRODUCTION (FR) 2010-03-17 EP disclosed
US-20080200983-A1 Photochromic Intraocular Lens IOLTECHNOLOGIE-PRODUCTION (FR) 2008-08-21 US disclosed
US-20080200983-A1 Photochromic Intraocular Lens IOLTECHNOLOGIE-PRODUCTION (FR) 2008-08-21 US disclosed
US-20070197750-A1 Polymerisable naphthopyrane derivatives and polymer materials obtained from these derivatives POLYMEREXPERT (FR) 2007-08-23 US disclosed
US-20070197750-A1 Polymerisable naphthopyrane derivatives and polymer materials obtained from these derivatives POLYMEREXPERT (FR) 2007-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197750-A1 Polymerisable naphthopyrane derivatives and polymer materials obtained from these derivatives CCND3, H1-3, H1-0 KDM4E 2000/4885MEN1 2826/4885NPC1 898/4885
US-20100317805-A1 POLYMERISABLE NAPHTHOPYRANE DERIVATIVES AND POLYMER MATERIALS OBTAINED FROM THESE DERIVATIVES C1S, H1-0, H1-3 KDM4E 3155/4885MEN1 1443/4885NPC1 1040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.